-
Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh MD, Ruiz-Palacios GM, Benfield T, Fatkenheuer G, Kortepeter MG, Atmar RL, Creech CB, Lundgren J, Babiker AG, Pett S, Neaton JD, Burgess TH, Bonnett T, Green M, Makowski M, Osinusi A, Nayak S, Lane HC, Members A-SG. 2020. Remdesivir for the Treatment of Covid-19—preliminary report. N Engl J Med. https://doi.org/10.1056/NEJMoa2007764
-
Breedveld FC, Dayer JM, 2000: Leflunomide: mode of action in the treatment of rheumatoid arthritis[J]. Ann Rheum Dis, 59, 841-849. doi: 10.1136/ard.59.11.841
-
Cai Q, Yang M, Liu D, Chen J, Shu D, Xia J, Liao X, Gu Y, Cai Q, Yang Y, Shen C, Li X, Peng L, Huang D, Zhang J, Zhang S, Wang F, Liu J, Chen L, Chen S, Wang Z, Zhang Z, Cao R, Zhong W, Liu Y, Liu L. 2020. Experimental treatment with favipiravir for COVID-19: an open-label control study. Engineering (Beijing). https://doi.org/10.1016/j.eng.2020.03.007
-
Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C, 2020: A trial of Lopinavir-Ritonavir in adults hospitalized with severe Covid-19[J]. N Engl J Med, 382, 1787-1799. doi: 10.1056/NEJMoa2001282
-
Chowdhury MS, Rathod J, Gernsheimer J, 2020: A rapid systematic review of clinical trials utilizing chloroquine and hydroxychloroquine as a treatment for COVID-19[J]. Acad Emerg Med, 27, 493-504. doi: 10.1111/acem.14005
-
Denison MR, Graham RL, Donaldson EF, Eckerle LD, Baric RS, 2011: Coronaviruses: an RNA proofreading machine regulates replication fidelity and diversity[J]. RNA Biol, 8, 270-279. doi: 10.4161/rna.8.2.15013
-
Devaux CA, Rolain JM, Colson P, Raoult D, 2020: New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19?[J]. Int J Antimicrob Agents, 55, 105938-. doi: 10.1016/j.ijantimicag.2020.105938
-
Fragoso YD, Brooks JB, 2015: Leflunomide and teriflunomide: altering the metabolism of pyrimidines for the treatment of autoimmune diseases[J]. Expert Rev Clin Pharmacol, 8, 315-320. doi: 10.1586/17512433.2015.1019343
-
Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G, Labella A, Manson D, Kubin C, Barr RG, Sobieszczyk ME, Schluger NW, 2020: Observational study of hydroxychloroquine in hospitalized patients with Covid-19[J]. N Engl J Med, 382, 2411-2418. doi: 10.1056/NEJMoa2012410
-
Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, Feldt T, Green G, Green ML, Lescure FX, Nicastri E, Oda R, Yo K, Quiros-Roldan E, Studemeister A, Redinski J, Ahmed S, Bernett J, Chelliah D, Chen D, Chihara S, Cohen SH, Cunningham J, D'Arminio Monforte A, Ismail S, Kato H, Lapadula G, L'Her E, Maeno T, Majumder S, Massari M, Mora-Rillo M, Mutoh Y, Nguyen D, Verweij E, Zoufaly A, Osinusi AO, DeZure A, Zhao Y, Zhong L, Chokkalingam A, Elboudwarej E, Telep L, Timbs L, Henne I, Sellers S, Cao H, Tan SK, Winterbourne L, Desai P, Mera R, Gaggar A, Myers RP, Brainard DM, Childs R, Flanigan T, 2020: Compassionate use of remdesivir for patients with severe Covid-19[J]. N Engl J Med, 382, 2327-2336. doi: 10.1056/NEJMoa2007016
-
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B, 2020: Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China[J]. Lancet, 395, 497-506. doi: 10.1016/S0140-6736(20)30183-5
-
Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M, 2020: Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period[J]. Science, 368, 860-868. doi: 10.1126/science.abb5793
-
Kupferschmidt K, Cohen J. 2020. WHO launches global megatrial of the four most promising coronavirus treatments. Science Magazine Mar. 22, 2020. Available at: https://www.sciencemag.org/news/2020/03/who-launches-global-megatrial-four-most-promising-coronavirus-treatments
-
NHC Diagnosis and treatment of novel coronavirus infected pneumonia, National Health Commission of the People's Republic of China (trial 7th edition)[EB/OL]. http://en.nhc.gov.cn/2020-03/29/c_78469.htm. Accessed 03 Mar 2020
-
NIAID. 2020. https://www.niaid.nih.gov/news-events/nih-clinical-trial-shows-remdesivir-accelerates-recovery-advanced-covid-19
-
Schrezenmeier E, Dorner T, 2020: Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology[J]. Nat Rev Rheumatol, 16, 155-166. doi: 10.1038/s41584-020-0372-x
-
Siegel D, Hui HC, Doerffler E, Clarke MO, Chun K, Zhang L, Neville S, Carra E, Lew W, Ross B, Wang Q, Wolfe L, Jordan R, Soloveva V, Knox J, Perry J, Perron M, Stray KM, Barauskas O, Feng JY, Xu Y, Lee G, Rheingold AL, Ray AS, Bannister R, Strickley R, Swaminathan S, Lee WA, Bavari S, Cihlar T, Lo MK, Warren TK, Mackman RL. 2017. Discovery and synthesis of a phosphoramidate prodrug of a Pyrrolo[2, 1-f][triazin-4-amino] adenine C-Nucleoside (GS-5734) for the treatment of Ebola and emerging viruses. J Med Chem, 60: 1648-1661
-
Singh A, Maqbool M, Mobashir M, Hoda N, 2017: Dihydroorotate dehydrogenase: a drug target for the development of antimalarials[J]. Eur J Med Chem, 125, 640-651. doi: 10.1016/j.ejmech.2016.09.085
-
Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y, Fu S, Gao L, Cheng Z, Lu Q, Hu Y, Luo G, Wang K, Lu Y, Li H, Wang S, Ruan S, Yang C, Mei C, Wang Y, Ding D, Wu F, Tang X, Ye X, Ye Y, Liu B, Yang J, Yin W, Wang A, Fan G, Zhou F, Liu Z, Gu X, Xu J, Shang L, Zhang Y, Cao L, Guo T, Wan Y, Qin H, Jiang Y, Jaki T, Hayden FG, Horby PW, Cao B, Wang C, 2020: Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial[J]. Lancet, 395, 1569-1578. doi: 10.1016/S0140-6736(20)31022-9
-
Warren TK, Jordan R, Lo MK, Ray AS, Mackman RL, Soloveva V, Siegel D, Perron M, Bannister R, Hui HC, Larson N, Strickley R, Wells J, Stuthman KS, Van Tongeren SA, Garza NL, Donnelly G, Shurtleff AC, Retterer CJ, Gharaibeh D, Zamani R, Kenny T, Eaton BP, Grimes E, Welch LS, Gomba L, Wilhelmsen CL, Nichols DK, Nuss JE, Nagle ER, Kugelman JR, Palacios G, Doerffler E, Neville S, Carra E, Clarke MO, Zhang L, Lew W, Ross B, Wang Q, Chun K, Wolfe L, Babusis D, Park Y, Stray KM, Trancheva I, Feng JY, Barauskas O, Xu Y, Wong P, Braun MR, Flint M, McMullan LK, Chen SS, Fearns R, Swaminathan S, Mayers DL, Spiropoulou CF, Lee WA, Nichol ST, Cihlar T, Bavari S, 2016: Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys[J]. Nature, 531, 381-385. doi: 10.1038/nature17180
-
Xiong R, Zhang L, Li S, Sun Y, Ding M, Wang Y, Zhao Y, Wu Y, Shang W, Jiang X, Shan J, Shen Z, Tong Y, Xu L, Chen Y, Liu Y, Zou G, Lavillete D, Zhao Z, Wang R, Zhu L, Xiao G, Lan K, Li H, Xu K. 2020. Novel and potent inhibitors targeting DHODH, a rate-limiting enzyme in de novo pyrimidine biosynthesis, are broad-spectrum antiviral against RNA viruses including newly emerged coronavirus SARS-CoV-2. bioRxiv 2020.03.11.983056. https://doi.org/10.1101/2020.03.11.983056
-
Yin W, Mao C, Luan X, Shen DD, Shen Q, Su H, Wang X, Zhou F, Zhao W, Gao M, Chang S, Xie YC, Tian G, Jiang HW, Tao SC, Shen J, Jiang Y, Jiang H, Xu Y, Zhang S, Zhang Y, Xu HE. 2020. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir. Science 368: 1499-1504